Vol 44 # 2 June 2012 - Kma.org.kw
Vol 44 # 2 June 2012 - Kma.org.kw
Vol 44 # 2 June 2012 - Kma.org.kw
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
121<br />
KUWAIT MEDICAL JOURNAL<br />
<strong>June</strong> <strong>2012</strong><br />
Original Article<br />
Determining the Effect of Sufentanil<br />
on Propofol Injection Pain<br />
Tuba Berra Saritas, Hale Borazan, Inci Kara, Sema Tuncer, Seref Otelcioglu<br />
Department of Anesthesiology and Reanimation, Selcuk University Meram Medical School, Konya, Turkey<br />
Kuwait Medical Journal <strong>2012</strong>; <strong>44</strong> (2): 121 - 124<br />
ABSTRACT<br />
Objectives: Propofol is a general anesthetic. Its most<br />
important disadvantage is pain on injection. Our aim was<br />
to evaluate the effectiveness of sufentanil on propofol<br />
injection pain (PIP).<br />
Design: Case control randomized double-blind study<br />
Setting: Anesthesia department of Selcuk University<br />
Meram Medical School , Turkey<br />
Subjects: A total of 160 adults, 18 to 65 years, ASA I-II<br />
patients, scheduled for operations under general anesthesia,<br />
were enrolled in this study. A 22-gauge intravenous (IV)<br />
catheter was inserted into a vein on the dorsum of the<br />
hand. Patients were randomly allocated to one of four<br />
groups to receive either saline or 0.5, 1, 2 mcg sufentanil<br />
in 2 ml volume. Thirty seconds after the intravenous (IV)<br />
injection of the pretreatment drug, 5 ml of 1% propofol at<br />
room temperature (Fresenius Kabi, Hamburg, Germany)<br />
was injected IV at rate of 0.5 ml/sec. Pain was assesed<br />
verbally and scored as none (0), mild (1), moderate (2),<br />
severe (3).<br />
Interventions: Prior injection of sufentanil or placebo<br />
Main Outcome Measures: Severity of PIP<br />
Results: Demographic data were comparable among<br />
four groups. Sufentanil at 1 and 2 mcg doses significantly<br />
decreased pain incidence when compared to the saline<br />
group (p < 0.05). Sufentanil 0.5 mcg had no effect (p ><br />
0.05). Although 2 mcg sufentanil decreased the incidence<br />
of PIP more than 1 mcg, there was no significant difference<br />
between these groups (p > 0.05).<br />
Conclusion: Sufentanil at one and 2 mcg doses reduced<br />
the incidence and severity of PIP<br />
KEY WORDS: general anesthesia, pain, propofol, sufentanil<br />
INTRODUCTION<br />
Propofol is a frequently used intravenous (IV)<br />
anesthetic for induction of anesthesia and for sedation<br />
in daycase surgery. The most important disadvantage<br />
of propofol is injection pain, which is reported in 28<br />
- 90% of patients [1] .<br />
Many different methods have been proposed to<br />
reduce the incidence and severity of this adverse<br />
effect of propofol. Pretreatment with alfentanil [2] , use<br />
of fentanyl [3] , local anesthetics [4] , metoclopramide [5] ,<br />
tramadol [6] , ketamine [7] , ondansetron [8] , addition of<br />
lidocaine [9,10] , alfentanil [11] ephedrine [12] , granisetron [13] ,<br />
and injection of propofol into a large antecubital vein<br />
or into a freely flowing intravenous (IV) line, are<br />
the techniques described for prevention of propofol<br />
injection pain (PIP) .<br />
Fentanyl, remifentanil, alfentanil and sufentanil<br />
can provide analgesia and assist anesthetic effects<br />
when used as presurgical medication, induction or<br />
maintenance agents, for postsurgical pain relief and<br />
neurolept and neuroleptanalgesia and as supplements<br />
to regional anesthesia. Opioids are also reported to<br />
be effective in preventing PIP [3,10,11] . Sufentanil is a<br />
selective μ receptor agonist, 5-10 times more effective<br />
analgesic than fentanyl and with a high safety [14] .<br />
However, there are few studies in literature that<br />
report sufentanil analgesic effect on PIP. In this study<br />
we tried to evaluate effectiveness of sufentanil, in<br />
prevention of PIP.<br />
SUBJECTS AND METHODS<br />
Ethics Committee approval was obtained from<br />
Selcuk University Meram Medical Faculty. All<br />
patients gave their informed and written consent.<br />
A total of 160 adult, aged between 18 to 65 years,<br />
ASA physical status I-II patients, scheduled for<br />
operations under general anesthesia, were enrolled<br />
into this randomized, double-blind study conducted<br />
in 2006 at the anesthesiology department of Meram<br />
Medical School of Selcuk University. Patients with<br />
Address correspondence to:<br />
Tuba Berra Saritas, MD, Associate Professor, Selcuk University Meram Medical School, Department of Anesthesiology and Reanimation,<br />
Konya,Turkey. Tel: 90 3322236166, Fax: 90 3322236181, E-mail:erdemtugba@hotmail.com